Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02864693 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Microprocessor Controlled and Carbon Fiber Prosthetic Feet in Transtibial Amputees

A NA study of Amputation, sponsored by Ability Prosthetics and Orthotics.

Completed
Registry status
NA
Development phase
30
Enrollment target
3
Study locations

NCT02864693 is a NA study of Amputation that has completed, run by Ability Prosthetics and Orthotics. The registered enrollment target is 30 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02864693, a NA study of Amputation, has completed, sponsored by Ability Prosthetics and Orthotics.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this research is to evaluate benefits of a microprocessor controlled prosthetic ankle-foot device compared to a non-microprocessor controlled or passive carbon fiber prosthetic ankle-foot device.

Conditions Studied

Interventions

  • DEVICE Kinnex
  • DEVICE Pacifica LP

Study Locations (3)

Maryland

  • Ability Prosthetics and Orthotics, Inc. - Hagerstown, MD - Hagerstown

North Carolina

  • Ability Prosthetics and Orthotics, Inc. - Charlotte, NC - Charlotte

Pennsylvania

  • Ability Prosthetics and Orthotics, Inc. - York, PA - York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-06
Est. Completion 2018-04
Phase NA

What the Registry Record Tells You About NCT02864693

The ClinicalTrials.gov registry entry for NCT02864693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (77% lower). The listed sponsor is Ability Prosthetics and Orthotics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Kinnex is the first listed.

NCT02864693 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, North Carolina, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02864693 about?

NCT02864693 is a clinical study titled "Comparative Effectiveness of Microprocessor Controlled and Carbon Fiber Prosthetic Feet in Transtibial Amputees". The purpose of this research is to evaluate benefits of a microprocessor controlled prosthetic ankle-foot device compared to a non-microprocessor controlled or passive carbon fiber prosthetic ankle-foot device.

What is the current status of trial NCT02864693?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-06. Estimated completion is 2018-04.

What conditions does trial NCT02864693 study?

This clinical trial studies the following conditions: Amputation.

What interventions are being tested in trial NCT02864693?

The interventions under investigation include: Kinnex (DEVICE), Pacifica LP (DEVICE).

Who is sponsoring clinical trial NCT02864693?

This trial is sponsored by Ability Prosthetics and Orthotics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02864693 being conducted?

This trial has 3 study locations across Maryland, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.